CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Revenue (Annual): 31.07M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 31.07M |
| December 31, 2022 | |
| December 31, 2021 | |
| December 31, 2020 | |
| December 31, 2019 | |
| December 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | 10.00M |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | 3.05M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
31.07M
Minimum
2023
31.07M
Maximum
2023
31.07M
Average
31.07M
Median
2023
Revenue (Annual) Benchmarks
| Gilead Sciences Inc | 27.12B |
| Assure Holdings Corp | 0.255M |
| Societal CDMO Inc (DELISTED) | 94.64M |
| AN2 Therapeutics Inc | -- |
| Madrigal Pharmaceuticals Inc | -- |